Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
IMPACT: This study explores the use of measuring plasma biomarkers at exacerbation of chronic obstructive pulmonary disease (COPD), providing insight into the underlying pathogenesis of these important events. RATIONALE: The use of measuring C-reactive protein (CRP) to confirm exacerbation, or to assess exacerbation severity, in COPD is unclear. Furthermore, it is not known whether there may be more useful systemic biomarkers. OBJECTIVE: To assess the use of plasma biomarkers in confirming exacerbation and predicting exacerbation severity. METHODS: We assessed 36 biomarkers in 90 paired baseline and exacerbation plasma samples from 90 patients with COPD. The diagnosis of exacerbation fulfilled both health care use and symptom-based criteria. Biomarker concentrations were related to clinical indices of exacerbation severity. Interrelationships between biomarkers were examined to gain information on mechanisms of systemic inflammation at exacerbation of COPD. MEASUREMENTS AND MAIN RESULTS: To confirm the diagnosis of exacerbation, the most selective biomarker was CRP. However, this was neither sufficiently sensitive nor specific alone (area under the receiver operating characteristic curve [AUC], 0.73; 95% confidence interval, 0.66-0.80). The combination of CRP with any one increased major exacerbation symptom recorded by the patient on that day (dyspnea, sputum volume, or sputum purulence) significantly increased the AUC to 0.88 (95% confidence interval, 0.82-0.93; p<0.0001). There were no significant relationships between biomarker concentrations and clinical indices of exacerbation severity. Interrelationships between biomarkers suggest that the acute-phase response is related, separately, to monocytic and lymphocytic-neutrophilic pathways. CONCLUSIONS: Plasma CRP concentration, in the presence of a major exacerbation symptom, is useful in the confirmation of COPD exacerbation. Systemic biomarkers were not helpful in predicting exacerbation severity. The acute-phase response at exacerbation was most strongly related to indices of monocyte function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic principles of ROC analysis
Metz, C. E. (1978) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(78)80014-2 · Cited by 6,026
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Self-citationDonaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Self-citationSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Toward a Consensus Definition for COPD Exacerbations
Rodriguez-Roisin, R. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.398s · Cited by 969
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Torzewski, J., Torzewski, M., Bowyer, D. E., Fröhlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., & Hombach, V. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1386 · Cited by 561
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., & Wedzicha, J. A. (2005) · Chest · doi:10.1378/chest.128.4.1995 · Cited by 480
Self-citationSpruit, M. A. (2003) · Thorax · doi:10.1136/thorax.58.9.752 · Cited by 476
Seemungal, T., MacCallum, P., Paul, E., Donaldson, G., Bhowmik, A., Jeffries, D., Meade, T., & Wedzicha, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Self-citationRaised CRP levels mark metabolic and functional impairment in advanced COPD
Broekhuizen, R. (2005) · Thorax · doi:10.1136/thx.2005.041996 · Cited by 439
Hurst, J. R., Perera, W. R., Wilkinson, T. M. A., Donaldson, G. C., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-704oc · Cited by 346 · cited 2×
“Markers reported to be higher in blood during exacerbation compared with the baseline state include CRP (12, 18–21), IL-8 (19), tumor necrosis factor- (22), leptin (22), endothelin-1 (23), eosinophil cationic protein (24), myeloperoxidase (24), fibrinogen (25), IL-6 ( 12 , 25), 1-antitrypsin (20, 21, 26), and leukotri…”
BackgroundSelf-citationBhakdi, S., Torzewski, M., Klouche, M., & Hemmes, M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2348 · Cited by 326
Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2006) · Chest · doi:10.1378/chest.129.2.317 · Cited by 317
Self-citationChanges in bronchial inflammation during acute exacerbations of chronic bronchitis
Gompertz, S., O'Brien, C., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99114901 · Cited by 292
Mannino, D. M., Ford, E. S., & Redd, S. C. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00185-2 · Cited by 291
Patel, V. P., Kreider, B. L., Li, Y., Li, H., Leung, K., Salcedo, T., Nardelli, B., Pippalla, V., Gentz, S., Thotakura, R., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1163 · Cited by 240
What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis
Hansell, A. L., Walk, J. A., & Soriano, J. B. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031403 · Cited by 240
Crooks, S. W., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15b09.x · Cited by 235
The Interrelationship of Sputum Inflammatory Markers in Patients with Chronic Bronchitis
HILL, A. T., BAYLEY, D., & STOCKLEY, R. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9901091 · Cited by 230
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
Roland, M. (2001) · Thorax · doi:10.1136/thorax.56.1.30 · Cited by 194
The Radiologic Manifestations of Legionnaire's Disease
Tan, M. J., Tan, J. S., File, T. M., Hamor, R. H., & Breiman, R. F. (2000) · Chest · doi:10.1378/chest.117.2.398 · Cited by 166
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
Dev, D., Wallace, E., Sankaran, R., Cunniffe, J., Govan, J. R. W., Wathen, C. G., & Emmanuel, F. X. S. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90515-7 · Cited by 162
Relationships Among Bacteria, Upper Airway, Lower Airway, and Systemic Inflammation in COPD
Hurst, J. R., Wilkinson, T. M. A., Perera, W. R., Donaldson, G. C., & Wedzicha, J. A. (2005) · CHEST Journal · doi:10.1016/s0012-3692(15)34470-6 · Cited by 146
Self-citationÇalıkoğlu, M. E., Şahin, G., Ünlü, A., Öztürk, C., Tamer, L., Ercan, B., Kanık, A., & Atik, U. (2004) · Respiration · doi:10.1159/000075648 · Cited by 125
Effects of Corticosteroids on Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Man, S. F. P., & Sin, D. D. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200406-034ms · Cited by 63
Relationships Among Bacteria, Upper Airway, Lower Airway, and Systemic Inflammation in COPD *
Hurst, J. R. (2005) · CHEST Journal · doi:10.1378/chest.127.4.1219 · Cited by 62
Self-citation
Cited by
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Self-citationChronic obstructive pulmonary disease
Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00470-6 · Cited by 1,219
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Metadata
- Authors
- Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10-15
- Volume
- 174
- Issue
- 8
- Pages
- 867-874
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2144400988
- Cited by
- 454
- References
- 32
- FWCI
- 22.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.